Article
Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development
24 May 2019
Abstract excerpt
Almost all patients with chronic liver diseases (CLD) show altered bone metabolism. Depending on the etiology, this manifests in a severe osteoporosis in up to 75% of the affected patients. Due to high prevalence, the generic term hepatic osteodystrophy (HOD) evolved, describing altered bone metabolism, decreased bone mineral density, and deterioration of bone structure in patients with CLD. Once developed, HOD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
